Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renin-Angiotensin-Aldosterone System”

77 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 77 results

Post-approval studies (Phase 4)UnknownNCT03953950
What this trial is testing

Effect of Add-on Spironolactone to Losartan Versus Losartan Alone on Peritoneal Membrane Among Peritoneal Dialysis Patients

Who this might be right for
End Stage Renal DiseasePeritoneal Dialysis
Chiang Mai University 84
Not applicableStudy completedNCT01691781
What this trial is testing

The Renin-Angiotensin-Aldosterone System and Parathyroid Hormone Control: The RAAS-PARC Study

Who this might be right for
Hyperparathyroidism
Brigham and Women's Hospital 41
Testing effectiveness (Phase 2)UnknownNCT02010905
What this trial is testing

Right Ventricular Dysfunction in Tetralogy of Fallot: Inhibition of the Renin-angiotensin-aldosterone System

Who this might be right for
Tetralogy of FallotHeart Defects, CongenitalVentricular Dysfunction, Right
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 120
Early research (Phase 1)WithdrawnNCT01432106
What this trial is testing

The Study of Novel Dual Renin Angiotensin Aldosterone System (RAAS) Blockade; Valsartan/Aliskiren in African American Patients With Hypertension and the Metabolic Syndrome

Who this might be right for
HypertensionMetabolic Syndrome
University of Michigan
Large-scale testing (Phase 3)Study completedNCT00853658
What this trial is testing

Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure

Who this might be right for
Chronic Heart Failure
Novartis Pharmaceuticals 7,064
Post-approval studies (Phase 4)Study completedNCT00430924
What this trial is testing

Inhibition of Aldosterone in Patients With Chronic Renal Disease

Who this might be right for
Kidney Failure, Chronic
Lene Boesby 42
Post-approval studies (Phase 4)Looking for participantsNCT06256991
What this trial is testing

Potassium Correction for RAAS Optimization in Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseasesHyperkalemiaHypertension
University Medical Center Groningen 44
Post-approval studies (Phase 4)Study completedNCT02034435
What this trial is testing

Endogenous Renin-Angiotensin-Aldosterone System and Glucose Metabolism

Who this might be right for
Metabolic Syndrome
Vanderbilt University Medical Center 44
Not applicableStudy completedNCT00572312
What this trial is testing

Optimalization of Nephroprotection Using Atorvastatin (Sortis)

Who this might be right for
Chronic Kidney DiseaseProteinuria
Medical University of Gdansk
Large-scale testing (Phase 3)Study completedNCT02040441
What this trial is testing

Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria

Who this might be right for
Diabetic NephropathyDiabetic Retinopathy
Peter Rossing 1,777
Not applicableStudy completedNCT04587375
What this trial is testing

Diagnosis of Endocrine Dysfunctions in Covid-19

Who this might be right for
Covid 19
University Hospital, Montpellier 50
Large-scale testing (Phase 3)Study completedNCT00853827
What this trial is testing

Safety and Efficacy of Aliskiren on the Progression of Atherosclerosis in Coronary Artery Disease Patients

Who this might be right for
Coronary Artery Disease (CAD)Coronary Atherosclerosis
Novartis Pharmaceuticals 613
Large-scale testing (Phase 3)Study completedNCT01885559
What this trial is testing

HALT Progression of Polycystic Kidney Disease Study B

Who this might be right for
Kidney, Polycystic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 486
Not applicableStudy completedNCT04366765
What this trial is testing

COVID-19 Survival - The COVIVA Study

Who this might be right for
COVID-19SARS-CoV 2
University Hospital, Basel, Switzerland 1,325
Not applicableStudy completedNCT04838470
What this trial is testing

Prognosis Predictors for Heart Failure

Who this might be right for
Heart FailureRehabilitationMorality+2 more
Chang Gung Memorial Hospital 792
Post-approval studies (Phase 4)Study completedNCT02200822
What this trial is testing

Systematic Withdrawal of Neurohumoral Blocker Therapy in Optimally Responding CRT Patients

Who this might be right for
Heart Failure (HF)
Hasselt University 80
Not applicableStudy completedNCT01173029
What this trial is testing

Renin-angiotensin-aldosterone System Polymorphisms in Resistant Hypertension and Adverse Cardiovascular Events

Who this might be right for
Systemic Arterial HypertensionHypertension Resistant to Conventional TherapyMyocardial Infarction+1 more
Universidade Gama Filho 92
Post-approval studies (Phase 4)Study completedNCT00400582
What this trial is testing

A Pharmacogenomic Study of Candesartan in Heart Failure

Who this might be right for
Heart Failure
Montreal Heart Institute 300
Post-approval studies (Phase 4)Ended earlyNCT01233635
What this trial is testing

Secondary Prevention of Atrial Fibrillation (Impact of Renin-Angiotensin-Aldosterone System Inhibition)

Who this might be right for
Atrial Fibrillation
University of Pittsburgh 228
Not applicableStudy completedNCT01716819
What this trial is testing

Role of the Renin Angiotensin Aldosterone System in the Mechanisms of Transition to Heart Failure in Abdominal Obesity

Who this might be right for
Obesity, Abdominal
Central Hospital, Nancy, France 101
Load More Results